Zomedica (ZOM) News Today $0.12 0.00 (-0.66%) Closing price 04:10 PM EasternExtended Trading$0.12 +0.00 (+0.17%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Zomedica Corp.: Zomedica Improves Efficiency and Cuts Costs by Moving to New HeadquartersFebruary 12, 2025 | finanznachrichten.deZomedica Corp.: Zomedica Launches the TRUFORMA Enhanced Endogenous ACTH Assay to aid in Equine PPID DiagnosisFebruary 6, 2025 | finanznachrichten.deZomedica (NYSEAMERICAN:ZOM) Shares Up 1.6% - Time to Buy?Zomedica (NYSEAMERICAN:ZOM) Shares Up 1.6% - Should You Buy?February 1, 2025 | marketbeat.comZomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% - Here's WhyZomedica (NYSEAMERICAN:ZOM) Trading Down 2.2% - Here's What HappenedJanuary 10, 2025 | marketbeat.comZomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% - Here's What HappenedZomedica (NYSEAMERICAN:ZOM) Shares Down 2.2% - Time to Sell?January 10, 2025 | marketbeat.comZomedica Corp.: Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel Hemostatic Gel in the Animal Health MarketJanuary 7, 2025 | finanznachrichten.deZomedica Corp.: Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial OfficerDecember 19, 2024 | finanznachrichten.deZomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% - Here's WhyZomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% - Here's What HappenedDecember 19, 2024 | marketbeat.comNoble Financial Comments on Zomedica FY2024 EarningsZomedica Corp. (NYSEAMERICAN:ZOM - Free Report) - Analysts at Noble Financial issued their FY2024 earnings estimates for shares of Zomedica in a research report issued on Monday, November 11th. Noble Financial analyst R. Leboyer anticipates that the company will post earnings per share of ($0.05)November 14, 2024 | marketbeat.comJohnny D. Powers Buys 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockNovember 13, 2024 | insidertrades.comZomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Acquires 100,000 SharesZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) Director Johnny D. Powers acquired 100,000 shares of Zomedica stock in a transaction dated Monday, November 11th. The stock was purchased at an average price of $0.12 per share, with a total value of $12,000.00. Following the completion of the purchase, the director now owns 2,425,000 shares of the company's stock, valued at approximately $291,000. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.November 12, 2024 | marketbeat.comZomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble FinancialNoble Financial upgraded Zomedica to a "strong-buy" rating in a research report on Monday.November 12, 2024 | marketbeat.comZomedica Corp.: Noble Capital Markets Initiates Equity Research Coverage on ZomedicaNovember 12, 2024 | finanznachrichten.deZomedica Positioned for Growth with Strategic Acquisitions and Strong Financial Performance: Buy RecommendationNovember 11, 2024 | markets.businessinsider.comZomedica Corp Posts Increased Revenue Amid LossNovember 9, 2024 | markets.businessinsider.comZomedica’s Revenue Up 10% Amid Global ExpansionNovember 9, 2024 | markets.businessinsider.comZomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...November 8, 2024 | finance.yahoo.comZomedica Corp. (ZOM) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comZomedica Corp. ZOM (U.S.: NYSE American)October 22, 2024 | wsj.comZomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue ChallengesOctober 9, 2024 | finance.yahoo.comZomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA ReachOctober 3, 2024 | benzinga.comZomedica Corp.: Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, MinnesotaSeptember 11, 2024 | finanznachrichten.deInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) CEO Acquires 100,000 Shares of StockSeptember 6, 2024 | insidertrades.comZomedica Corp. (NYSEAMERICAN:ZOM) CEO Larry C. Heaton II Buys 100,000 SharesZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) CEO Larry C. Heaton II purchased 100,000 shares of Zomedica stock in a transaction on Thursday, September 5th. The stock was bought at an average cost of $0.12 per share, for a total transaction of $12,000.00. Following the transaction, the chief executive officer now directly owns 400,000 shares in the company, valued at $48,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.September 5, 2024 | marketbeat.comJohnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockAugust 29, 2024 | insidertrades.comZomedica Corp.: Zomedica's Assisi Loop Product Line Designated as Fear Free Preferred ProductAugust 29, 2024 | finanznachrichten.deZomedica Corp. (NYSEAMERICAN:ZOM) Director Buys $13,000.00 in StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) Director Johnny D. Powers bought 100,000 shares of the stock in a transaction dated Wednesday, August 28th. The shares were acquired at an average price of $0.13 per share, with a total value of $13,000.00. Following the completion of the purchase, the director now directly owns 2,325,000 shares of the company's stock, valued at $302,250. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.August 28, 2024 | marketbeat.comWORK Medical Technology Group LTD Ordinary Shares (WOK)August 23, 2024 | sg.finance.yahoo.comZomedica Corp.: Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary ConferenceAugust 20, 2024 | finanznachrichten.deZomedica (NYSEAMERICAN:ZOM) Stock Price Down 5.5%Zomedica (NYSEAMERICAN:ZOM) Trading Down 5.5%August 16, 2024 | marketbeat.comZOM Stock Earnings: Zomedica Misses Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comZomedica Taps Into Costa Rica With Strategic Partnership With SIRE VeterinarioAugust 14, 2024 | msn.comZomedica Corp.: Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central AmericaAugust 14, 2024 | finanznachrichten.deZomedica Corp.: The United States Eventing Association Names Zomedica's PulseVet as the Official Shock Wave of the USEAJuly 19, 2024 | finanznachrichten.deZomedica Corp. (NYSEAMERICAN:ZOM) VP Russell Kevin Klass Buys 299,993 SharesJune 14, 2024 | insidertrades.comRussell Kevin Klass Buys 299,993 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) VP Russell Kevin Klass purchased 299,993 shares of the company's stock in a transaction dated Wednesday, June 12th. The stock was acquired at an average price of $0.16 per share, with a total value of $47,998.88. Following the completion of the transaction, the vice president now owns 2,000,050 shares of the company's stock, valued at approximately $320,008. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.June 13, 2024 | marketbeat.comThe 3 Most Undervalued Penny Stocks to Buy in June 2024June 13, 2024 | investorplace.comZomedica Corp.: Zomedica Enhances TRUFORMA Platform With Launch of Advanced Canine Cortisol AssayMay 29, 2024 | finanznachrichten.deZomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol AssayMay 29, 2024 | finance.yahoo.comZomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) TherapyMay 23, 2024 | finance.yahoo.comZomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 21, 2024 | finance.yahoo.comInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) Director Purchases 100,000 Shares of StockMay 18, 2024 | insidertrades.comZomedica Corp. (NYSEAMERICAN:ZOM) COO Anthony K. Blair Buys 150,000 SharesMay 15, 2024 | insidertrades.comInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) COO Buys 150,000 Shares of StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) COO Anthony K. Blair purchased 150,000 shares of the stock in a transaction dated Monday, May 13th. The shares were bought at an average price of $0.14 per share, with a total value of $21,000.00. Following the completion of the acquisition, the chief operating officer now directly owns 150,000 shares of the company's stock, valued at approximately $21,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.May 14, 2024 | marketbeat.comZomedica And 3 Other Stocks Under $3 Insiders Are BuyingMay 14, 2024 | msn.comLarry C. Heaton II Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockMay 14, 2024 | insidertrades.comZomedica Corp (ZOM) Q1 2024 Earnings: Revenue Climbs Amidst Rising Costs, Aligns with Analyst ...May 10, 2024 | finance.yahoo.comZomedica earnings: here's what Wall Street expectsMay 9, 2024 | markets.businessinsider.comZomedica Corp.: Zomedica Expands International Reach with CE Certification for VetGuardian SystemMay 6, 2024 | finanznachrichten.deZomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call TranscriptApril 2, 2024 | msn.com Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address ZOM Media Mentions By Week ZOM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZOM News Sentiment▼0.000.60▲Average Medical News Sentiment ZOM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZOM Articles This Week▼01▲ZOM Articles Average Week Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PROK News ABVX News ORGO News CMPX News AKBA News PRTC News ALT News CDXC News KMDA News MREO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:ZOM) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZOM Stock Alerts